SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-014251
Filing Date
2024-01-24
Accepted
2024-01-24 16:22:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d799844dsc13ga.htm SC 13G/A 42295
  Complete submission text file 0001193125-24-014251.txt   43647
Mailing Address C/O MURRAY ENTERPRISES, LLC 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
MURRAY JAMES B JR (Filed by) CIK: 0001008670 (see all company filings)

Type: SC 13G/A

Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92677 | Film No.: 24556785
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)